Literature DB >> 4937510

Cannabivarin and tetrahydrocannabivarin, two new constituents of hashish.

F W Merkus.   

Abstract

Entities:  

Mesh：

Year:  1971        PMID： 4937510     DOI： 10.1038/232579a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.

Authors:  Adèle Thomas; Lesley A Stevenson; Kerrie N Wease; Martin R Price; Gemma Baillie; Ruth A Ross; Roger G Pertwee
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 2.  The psychopharmacology of "cannabis sativa": a review.

Authors:  L Mills; P Brawley
Journal:  Agents Actions       Date:  1972

Review 3.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

4.  Anticipatory nausea in animal models: a review of potential novel therapeutic treatments.

Authors:  Erin M Rock; Cheryl L Limebeer; Linda A Parker
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

5.  Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.

Authors:  Erin M Rock; Martin A Sticht; Marnie Duncan; Colin Stott; Linda A Parker
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

6.  Constituents of Cannabis Sativa.

Authors:  Erin M Rock; Linda A Parker
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Medical marijuana-an obesity problem or opportunity?

Authors:  Frank L Greenway; John P Kirwan
Journal:  Int J Obes (Lond)       Date:  2019-02-12       Impact factor: 5.095

Review 8.  The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

9.  Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice.

Authors:  Gernot Riedel; Paola Fadda; Susan McKillop-Smith; Roger G Pertwee; Bettina Platt; Lianne Robinson
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

10.  Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.

Authors:  Frances R Levin; John J Mariani; Daniel J Brooks; Shan Xie; Kathleen A Murray
Journal:  Drug Alcohol Depend       Date:  2009-09-03       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.